The clinical oncology next generation sequencing market consists of sales of devices and equipment used in clinical oncology next generation sequencing and related services by entities (organizations, sole traders and partnerships) that manufacture clinical oncology next generation sequencing equipment. Next generation sequencing is a process used to determine the sequence of nucleotides in a section of DNA and is used for oncology research. Only goods and services traded between entities or sold to end consumers are included.
Global Clinical Oncology Next Generation Sequencing Market Size And Drivers:
The global clinical oncology next generation sequencing market is expected to grow from $0.44 billion in 2020 to $0.56 billion in 2021 at a compound annual growth rate (CAGR) of 27.3%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global clinical oncology next generation sequencing market is expected to reach $1.05 billion in 2025 at a CAGR of 17%. The rise in the number of cancer cases across the globe is likely to contribute to the growth of the clinical oncology next generation sequencing market during the forecast period.
Request For A Sample For The Global Clinical Oncology Next Generation Sequencing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3344&type=smp
Trends In The Global Clinical Oncology Next Generation Sequencing Market
Companies in the clinical oncology next generation sequencing are increasingly investing in automation of workflow to increase precision and reduce the sample-to-sample variability. For instance, Agilent automation solutions have developed an automation system that allows increasing the number of reactions that can perform in parallel, and reducing the amount of sample processing time, and increasing the number of samples which can be processed while reducing the variability amount from sample to sample. Companies such as Sophia Genetics are also investing in data-driven medicine that looks into automating DNA sequencing to better diagnose and treat patients.
Global Clinical Oncology Next Generation Sequencing Market Segments:
The global clinical oncology next generation sequencing market is further segmented –
By Technology: Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible Dye Termination Sequencing, Nano-Pore Sequencing
By Application: Screening, Companion Diagnostics, Other Diagnostics
By End User: Hospital Laboratories, Clinical Research Organizations, Diagnostic laboratories
By Geography: The global clinical oncology next generation sequencing market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Report For The Global Clinical Oncology Next Generation Sequencing Market At:
https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report-2020-30-covid-19-growth-and-change
Clinical Oncology Next Generation Sequencing Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides clinical oncology next generation sequencing market overviews, analyzes and forecasts market size and growth for the global clinical oncology next generation sequencing market, clinical oncology next generation sequencing market share, clinical oncology next generation sequencing market players, clinical oncology next generation sequencing market segments and geographies, clinical oncology next generation sequencing market’s leading competitors’ revenues, profiles and market shares. The clinical oncology next generation sequencing market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
